Genmab — August 2013
-
jeg ved ikke, om man kan lægge noget i det - i meddelelsen 31 maj, talte de om at ansøgning inden for "coming months" - og i CC for et par uger siden talte Jan om "very soon"
-
...og det er tre måneder siden fase III data kom
-
kan et ultra-positivt view være, at GEN/GSK kan nå en action date omkring samme tid som GA101?
-
Haha - men det er vel også fuldstændig ude af Jans hænder, hvad han har lov til at sige videre til markedet.
-
Jeg ser stadig rigtig mange usikkerhedsmomenter - men er samtidig voldsomt beroliget af den totale mangel på insidersalg
-
i øvrigt er der årsdag for Dara-aftalen i dag. Mon det bliver fejret efter luk...?
-
Mon ikke vi kan vente nogle gode milestones i dara: J&J ($JNJ) knows how to do a big licensing deal with some serious short-term incentives tied to it.
Read more: UPDATED: J&J hands over $75M payout as FDA countdown begins for ibrutinib - FierceBiotech http://www.fiercebiotech.com/story/jj-hands-over-75m-payout-fda-countdown-begins-ibrutinib/2013-08-29#ixzz2dTsBb5Ku
Subscribe at FierceBiotech
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind